$3.4 billion in 2026 sales are projected to climb to $18.4 billion by 2036, implying an 18.4% annual growth rate for gene-edited and precision-bred crop ingredients.
CRISPR is expected to lead technology spending with a 61.8% share in 2026, as buyers favor targeted traits that can show measurable yield or ingredient-quality gains in field and processor tests.
Cacao is forecast to dominate crops with a 40.7% share and yield traits to lead revenue at 56.0%, reflecting demand for supply security and more consistent processing output.
Regulatory and procurement hurdles still constrain rollout: EU rules took effect on July 16, 2026 but apply from July 17, 2028, while food companies continue to require labeling, traceability and case-by-case documentation.
Country growth rates remain relatively tight—China leads the profiled markets at 17.1% CAGR, ahead of Brazil at 16.7%, while the U.S. is seen growing 15.9% through 2036.